DELEK GP SP.ADR/1/01/O.N (F:6D40) — Stock Price
DELEK GP SP.ADR/1/01/O.N (F:6D40) is currently trading at €29.20 EUR, down 32.09% today. Over the past 52 weeks, shares have ranged between €13.00 and €43.00. This page tracks DELEK GP SP.ADR/1/01/O.N's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is DELEK GP SP.ADR/1/01/O.N worth.
DELEK GP SP.ADR/1/01/O.N (6D40) Stock Price Chart — Daily History & Trading Volume
The chart below tracks DELEK GP SP.ADR/1/01/O.N's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
DELEK GP SP.ADR/1/01/O.N Income Statement — Revenue, Profit & Earnings by Year
DELEK GP SP.ADR/1/01/O.N's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €4.15 Billion | €4.63 Billion | €3.80 Billion | €11.99 Billion | €7.84 Billion |
| Cost of Revenue | €2.01 Billion | €2.04 Billion | €1.22 Billion | €5.20 Billion | €3.66 Billion |
| Gross Profit | €2.14 Billion | €2.60 Billion | €2.58 Billion | €6.80 Billion | €4.17 Billion |
| Research & Development | — | — | — | — | — |
| SG&A | €79.00 Million | €84.00 Million | €76.00 Million | €135.00 Million | €81.00 Million |
| Total Operating Expenses | €2.22 Billion | €2.19 Billion | €1.36 Billion | €5.60 Billion | €3.81 Billion |
| Operating Income | €1.93 Billion | €2.44 Billion | €2.44 Billion | €6.39 Billion | €4.03 Billion |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | — |
| Interest Expense | €801.00 Million | €833.00 Million | €994.00 Million | €1.32 Billion | €1.58 Billion |
| Income Before Tax | €1.55 Billion | €2.24 Billion | €1.74 Billion | €9.15 Billion | €2.83 Billion |
| Income Tax Expense | — | — | — | — | — |
| Net Income | €3.26 Billion | €1.40 Billion | €1.59 Billion | €3.98 Billion | €1.43 Billion |
DELEK GP SP.ADR/1/01/O.N Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes DELEK GP SP.ADR/1/01/O.N's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €56.54 Billion | €52.35 Billion | €43.84 Billion | €43.07 Billion | €31.40 Billion |
| Total Current Assets | €29.65 Billion | €8.78 Billion | €6.73 Billion | €7.59 Billion | €4.35 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | €9.00 Million | €173.00 Million | €2.00 Million | €4.00 Million | €67.00 Million |
| Net Receivables | €820.00 Million | €1.99 Billion | €1.69 Billion | €1.13 Billion | €825.00 Million |
| Inventory | €186.00 Million | €1.22 Billion | €679.00 Million | €622.00 Million | €552.00 Million |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | €962.00 Million | €4.66 Billion | €3.38 Billion | €3.28 Billion | €2.71 Billion |
| Total Liabilities | €39.28 Billion | €33.81 Billion | €28.91 Billion | €30.19 Billion | €26.21 Billion |
| Total Current Liabilities | €21.82 Billion | €8.32 Billion | €5.89 Billion | €7.91 Billion | €4.92 Billion |
| Long-term Debt | €13.82 Billion | €12.68 Billion | €13.33 Billion | €13.78 Billion | €14.50 Billion |
| Net Debt | €12.27 Billion | €12.57 Billion | €12.75 Billion | €14.49 Billion | €13.71 Billion |
| Total Stockholder Equity | €10.08 Billion | €8.72 Billion | €9.52 Billion | €8.56 Billion | €2.60 Billion |
| Retained Earnings | €10.20 Billion | €7.98 Billion | €7.52 Billion | €7.03 Billion | €3.05 Billion |
DELEK GP SP.ADR/1/01/O.N Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how DELEK GP SP.ADR/1/01/O.N generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €2.71 Billion | €1.71 Billion | €1.83 Billion | €6.83 Billion | €3.51 Billion |
| Capital Expenditures | €1.19 Billion | €567.00 Million | €564.00 Million | €1.57 Billion | €1.03 Billion |
| Free Cash Flow | €1.53 Billion | €1.14 Billion | €1.26 Billion | €5.26 Billion | €2.48 Billion |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — |
| Dividends Paid | €-1.03 Billion | €-940.00 Million | €-132.00 Million | — | — |
| Stock-Based Compensation | €7.00 Million | €4.00 Million | €5.00 Million | €53.00 Million | €0.00 |
| Depreciation | €822.00 Million | €475.00 Million | €369.00 Million | €2.91 Billion | €797.00 Million |
| Change in Cash | €-1.88 Billion | €-540.00 Million | €-195.00 Million | €1.01 Billion | €745.00 Million |
DELEK GP SP.ADR/1/01/O.N Earnings History — EPS Actual vs. Analyst Estimates
Track DELEK GP SP.ADR/1/01/O.N's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Aug 19, 2026 | — | — | — |
| May 20, 2026 | — | — | — |
| Mar 25, 2026 | — | — | — |
| Nov 20, 2025 | — | — | — |
| Aug 25, 2025 | — | — | — |
| May 26, 2025 | — | — | — |
| Mar 25, 2025 | — | — | — |
| Nov 20, 2024 | — | — | — |